This provides evidence that MLKL activation in COVID-19 may not occur downstream of activated RIPK1–RIPK3 to promote necroptosis, but rather by alternative RIPK3-independent inflammatory responses such as via IFNγ as previously reported in inflammatory arthritis [167]. Here, RIPK1 is linked to COVID-19.